{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:26:54Z","timestamp":1780961214920,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","award":["1043\/UN3.15\/PT\/2021"],"award-info":[{"award-number":["1043\/UN3.15\/PT\/2021"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vaccine.2022.05.059","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T02:29:54Z","timestamp":1653618594000},"page":"4046-4056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2"],"prefix":"10.1016","volume":"40","author":[{"given":"Gatot","family":"Soegiarto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laksmi","family":"Wulandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewajani","family":"Purnomosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dhia Fahmita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendra","family":"Ikhwan Gautama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satrio","family":"Tri Hadmoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Edwin Prasetyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagus","family":"Aulia Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Prasetyaningtyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujo","family":"Prawiro Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cita","family":"Rosita Sigit Prakoeswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anang","family":"Endaryanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desak","family":"Gede Agung Suprabawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damayanti","family":"Tinduh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eka","family":"Basuki Rachmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Astha Triyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Wahyuhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catur","family":"Budi Keswardiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feby","family":"Elyana Wardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitriyah","family":"Mayorita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunuk","family":"Kristiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Baskoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deasy","family":"Fetarayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wita","family":"Kartika Nurani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delvac","family":"Oceandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2022.05.059_b0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.059_b0010","doi-asserted-by":"crossref","unstructured":"COVID-19 vaccines: acting on the evidence. Nat Med 2021;27(2):183.","DOI":"10.1038\/s41591-021-01261-5"},{"issue":"25","key":"10.1016\/j.vaccine.2022.05.059_b0015","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"issue":"10267","key":"10.1016\/j.vaccine.2022.05.059_b0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2020","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.vaccine.2022.05.059_b0025","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.059_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.vaccine.2022.05.059_b0035","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial","volume":"326","author":"Al Kaabi","year":"2021","journal-title":"JAMA"},{"issue":"44","key":"10.1016\/j.vaccine.2022.05.059_b0045","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.vaccine.2021.09.052","article-title":"A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18\u201359 years: An interim analysis in Indonesia","volume":"39","author":"Fadlyana","year":"2021","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.059_b0050","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.059_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2022.05.059_b0060","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.05.059_b0070","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.eclinm.2021.100928","article-title":"Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine","volume":"36","author":"Pellini","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2022.05.059_b0075","doi-asserted-by":"crossref","first-page":"e12316","DOI":"10.7717\/peerj.12316","article-title":"The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: a prospective study in Japan","volume":"9","author":"Mitsunaga","year":"2021","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dom.14547","article-title":"Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: the CAVEAT study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.vaccine.2022.05.059_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3694957","article-title":"Changes of regulatory T Cells and of proinflammatory and immunosuppressive cytokines in patients with Type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Qiao","year":"2016","journal-title":"J Diabetes Res"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.059_b0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","article-title":"Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis","volume":"107","author":"Bae","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.vaccine.2022.05.059_b0095","article-title":"Immune system and COVID-19 by sex differences and age","volume":"17","author":"Ciarambino","year":"2021","journal-title":"Womens Health (Lond)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06466-0","article-title":"Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort","volume":"21","author":"Yates","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/21645515.2018.1514221","article-title":"Comparison of three sample size calculation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints","volume":"15","author":"Yang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.059_b0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"38","author":"Unger","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.vaccine.2022.05.059_b0115","series-title":"Sample size determination in health studies: a practical manual","author":"Lwanga","year":"1991"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11906-014-0507-z","article-title":"Inflammation and hypertension: new understandings and potential therapeutic targets","volume":"17","author":"De Miguel","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.059_b0125","first-page":"245","article-title":"Inflammation in hypertension","volume":"5","author":"Savoia","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"49","key":"10.1016\/j.vaccine.2022.05.059_b0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID's Role in Pandemic Response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly"},{"issue":"7872","key":"10.1016\/j.vaccine.2022.05.059_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.059_b0140","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/cid\/ciab381","article-title":"Age-dependent immune response to the Biontech\/Pfizer BNT162b2 coronavirus disease 2019 vaccination","volume":"73","author":"M\u00fcller","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.059_b0145","doi-asserted-by":"crossref","first-page":"e2124331","DOI":"10.1001\/jamanetworkopen.2021.24331","article-title":"Comparison of SARS-CoV-2 antibody response by age among recipients of the BNT162b2 vs the mRNA-1273 vaccine","volume":"4","author":"Richards","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.059_b0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s43587-021-00114-7","article-title":"SARS-CoV-2, COVID-19 and the Ageing Immune System","volume":"1","author":"Bartleson","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.vaccine.2022.05.059_b0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3465","article-title":"Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine","volume":"38","author":"Watanabe","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.vaccine.2022.05.059_b0165","doi-asserted-by":"crossref","unstructured":"Yelin I, Katz R, Herzel E, et al. Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities. medRxiv 2021: 2021.03.16.21253686.","DOI":"10.1101\/2021.03.16.21253686"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.059_b0170","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/vaccines9091042","article-title":"Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine","volume":"9","author":"Nomura","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.059_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-021-01162-5","article-title":"T Cell immunometabolism and redox signaling in hypertension","volume":"23","author":"Mattson","year":"2021","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.059_b0180","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/ars.2020.8042","article-title":"The redox-metabolic couple of T lymphocytes: potential consequences for hypertension","volume":"34","author":"Moshfegh","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.059_b0185","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/HJH.0000000000002456","article-title":"Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications","volume":"38","author":"Rai","year":"2020","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.059_b0190","first-page":"383","article-title":"Inflammation and arterial hypertension-pathophysiological links and clinical aspects","volume":"46","author":"Balan","year":"2020","journal-title":"Curr Health Sci J"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.059_b0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.ackd.2019.03.001","article-title":"Inflammation, immunity, and oxidative stress in hypertension-partners in crime?","volume":"26","author":"Barrows","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.059_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10369","article-title":"Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination","volume":"7","author":"Fourati","year":"2016","journal-title":"Nat Commun"},{"issue":"42","key":"10.1016\/j.vaccine.2022.05.059_b0205","article-title":"Implications of inflammatory states on dysfunctional immune responses in aging and obesity","volume":"2","author":"Thomas","year":"2021","journal-title":"Front Aging"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.059_b0210","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41440-020-0439-8","article-title":"Association of triglycerides to high-density lipoprotein-cholesterol ratio with risk of incident hypertension","volume":"43","author":"Liu","year":"2020","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.059_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41440-019-0333-4","article-title":"Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation","volume":"43","author":"Iyonaga","year":"2020","journal-title":"Hypertens Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:32Z","timestamp":1759403612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22006764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0264410X22006764"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}